These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25033163)

  • 41. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
    Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
    Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive and psychosocial features of childhood and juvenile MS.
    Amato MP; Goretti B; Ghezzi A; Lori S; Zipoli V; Portaccio E; Moiola L; Falautano M; De Caro MF; Lopez M; Patti F; Vecchio R; Pozzilli C; Bianchi V; Roscio M; Comi G; Trojano M;
    Neurology; 2008 May; 70(20):1891-7. PubMed ID: 18474844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.
    Strober L; DeLuca J; Benedict RH; Jacobs A; Cohen JA; Chiaravalloti N; Hudson LD; Rudick RA; LaRocca NG;
    Mult Scler; 2019 Nov; 25(13):1781-1790. PubMed ID: 30334474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis.
    Portaccio E; Goretti B; Lori S; Zipoli V; Centorrino S; Ghezzi A; Patti F; Bianchi V; Comi G; Trojano M; Amato MP;
    Mult Scler; 2009 May; 15(5):620-6. PubMed ID: 19318511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examining the relationship between cognition and driving performance in multiple sclerosis.
    Schultheis MT; Weisser V; Ang J; Elovic E; Nead R; Sestito N; Fleksher C; Millis SR
    Arch Phys Med Rehabil; 2010 Mar; 91(3):465-73. PubMed ID: 20298841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study.
    Glanz BI; Healy BC; Hviid LE; Chitnis T; Weiner HL
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):38-43. PubMed ID: 21746743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Procedural Variations in the Stroop and the Symbol Digit Modalities Test: impact on patients with multiple sclerosis.
    Hughes AJ; Denney DR; Owens EM; Lynch SG
    Arch Clin Neuropsychol; 2013 Aug; 28(5):452-62. PubMed ID: 23735824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
    Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of processing speed in children with mild TBI: a "first look" at the validity of pediatric ImPACT.
    Newman JB; Reesman JH; Vaughan CG; Gioia GA
    Clin Neuropsychol; 2013; 27(5):779-93. PubMed ID: 23597006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neuropsychological tests in multiple sclerosis].
    Takeda A
    Nihon Rinsho; 2014 Nov; 72(11):1989-94. PubMed ID: 25518382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distraction adds to the cognitive burden in multiple sclerosis.
    Patel VP; Zambrana A; Walker LA; Herrmann N; Feinstein A
    Mult Scler; 2017 Jan; 23(1):106-113. PubMed ID: 27012660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regression-based norms improve the sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
    Smerbeck AM; Parrish J; Yeh EA; Weinstock-Guttman B; Hoogs M; Serafin D; Krupp L; Benedict RH
    Clin Neuropsychol; 2012; 26(6):985-1002. PubMed ID: 22849345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.